IPX: Bullish Pennant detected on 29 Apr 2026

IPX has formed a bullish pennant following a strong rally driven by the March 2026 quarterly report and the successful transition of Virginia operations to 24/7 continuous production schedule. The pattern shows solid structure (14/15) with healthy breakout (13/13) and volume dynamics (12/12), yielding an overall score of 78. The stock is trading at $30.72, consolidating between key support at $25.76 and resistance at $34.84. Volume is elevated at 1.25x average with positive MACD histogram (+0.38), suggesting buyers remain engaged. At 47.69 RSI, momentum is neutral, neither overbought nor oversold. The pattern quality indicates 61.58% win probability on breakout.

The Virginia operations transitioned to 24/7 continuous production, indicating a crucial shift from commissioning to ongoing operations for titanium powder production. HAMR™ powder production systems have been commissioned and are now in ramp-up, with IperionX targeting run-rate production of ~200 tpa of titanium powder by end-CY2026. BTIG initiated coverage with a Buy rating and a $40 price target on March 27. An investor webinar hosted by CEO Taso Arima on April 28 is expected to offer detail on the company's resource outlook and strategy. The company ended the quarter with US$48.2 million in cash. These catalysts align with sector bullish regime (54/100), supporting near-term momentum.

A breakout above $34.84 resistance would target the conservative measure move at $33.01, though price has already touched this level. Volume must sustain above 1.25x average on breakout to confirm conviction. The pattern invalidates below key support at $25.76, a 16.1% drawdown from current price. With 61.58% historical win probability, the setup indicates a modestly favorable risk-reward profile. The April 28 webinar provides a near-term catalyst that could accelerate breakout or rejection within days.

IperionX is experiencing volatility, with elevated beta at 2.41x the market—meaning outsized price swings in either direction. The company plans to displace about 5% of US imports next year, a small penetration target that hinges on execution and customer conversion. Stock has declined 45.42% over three months, suggesting momentum exhaustion risk despite recent gains. The Titan DFS is targeted for completion in mid-2026, creating binary risk—delays could trigger sharp selloff. No current earnings call or results announcements on the near-term horizon, reducing near-term catalysts post-webinar. Commercialization remains in early-stage (prototype/low-rate production), adding execution risk.